Silencing SFRP1 in bone mesenchymal stem cells alleviates pediatric B-ALL-driven bone loss by activating Wnt/β-catenin signaling

Background: Bone loss is the most common skeletal complication of childhood acute lymphoblastic leukemia (ALL) and seriously affects the long-term survival quality of children. However, the mechanisms behind bone loss are complicated and need to be elucidated. This study seeks to examine the princip...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mengxia Li, Xu He, Xingzhi Liu, Mimi Chen, Qian Sun, Ronghui Yu, Wendong Liu, Qi Wang, Guanghao Su, Qin Shi, Xiaodong Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-03-01
coleção:	Journal of Orthopaedic Translation
Assuntos:	Bone loss Mesenchymal stem cells Pediatric acute lymphoblastic leukemia SFRP1 shSFRP1@Lipo-E7
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2214031X26000264
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!